AlphaYou
Overview
No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.
Key stats
Aug 22- Open
- $114.02
- 52-wk high
- $134.38
- High
- $116.66
- 52-wk low
- $81.39
- Low
- $113.45
- Prev close
- $114.14
Smart money
Earnings
Earnings came in 2.3% above what analysts expected.
Financials
What it sold, what it cost, what was left.
Jun 2025Sep 2025Dec 2025Mar 2026
| USD | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $11.14B | $11.37B | $11.46B | $11.16B |
| Cost of what it sold | $4.85B | $5.03B | $4.92B | $4.88B |
| Gross profit | $6.29B | $6.34B | $6.54B | $6.28B |
| What it spent | ||||
| Research and development | $732.0M | $785.0M | $735.0M | $756.0M |
| Sales and admin | $3.09B | $3.05B | $3.13B | $3.74B |
| Other operating costs | $414.0M | $472.0M | $422.0M | -$55.0M |
| Total operating expenses | $4.24B | $4.31B | $4.29B | $4.44B |
| What was left | ||||
| Operating profit | $2.05B | $2.06B | $2.25B | $1.84B |
| Interest on debt | $121.0M | $44.0M | $120.0M | $174.0M |
| Profit before tax | $2.15B | $2.18B | $2.36B | $1.45B |
| Tax | $371.0M | $536.0M | $582.0M | $372.0M |
| Net profit | $1.78B | $1.64B | $1.78B | $1.08B |
| EBITDA | $3.05B | $3.09B | $2.82B | $2.25B |
Technicals
Price structure
This stock is in a strong uptrend, and looks overbought after a fast run-up.
Trend
Strong uptrend
85 / 100
RSI 14
81overbought
20D volatility
20%annualized
52-week range
$81.39$134.38
20D support
News
What the news says
50 articles · 7 days
Coverage is bullish
Tone of tracked coverage
Abbott Laboratories to pay $670 million to settle cases, claims over its formula for premature babies
Leans bearishAug 20Abbott agrees to $670 million settlement of infant formula cases
NeutralAug 20Abbott in $670M settlement for some NEC infant formula claims (ABT:NYSE)
BearishAug 20
